Gleeson Laura L, Ludlow Aoife, Clyne Barbara, Ryan Ben, Argent Rob, Barlow James, Mellon Lisa, De Brún Aoife, Pate Muriel, Kirke Ciara, Moriarty Frank, Flood Michelle
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, 123 St Stephen's Green, Dublin 2, Ireland.
Department of General Practice, RCSI University of Medicine and Health Sciences, 123 St Stephen's Green, Dublin 2, Ireland.
Explor Res Clin Soc Pharm. 2022 Dec;8:100193. doi: 10.1016/j.rcsop.2022.100193. Epub 2022 Oct 13.
A number of significant changes designed to reduce the spread of COVID-19 were introduced in primary care during the COVID-19 pandemic. In Ireland, these included fundamental legislative and practice changes such as permitting electronic transfer of prescriptions, extending duration of prescription validity, and encouraging virtual consultations. Although such interventions served an important role in preventing the spread of infection, their impact on practice and patient care is not yet clear. The aim of this study was to investigate patient and healthcare professional (pharmacist and general practitioner) experiences to understand the impact of COVID-19 on primary care and medication safety during the first two years of the COVID-19 pandemic in Ireland.
A qualitative study using semi-structured interviews was undertaken between October 2021 and January 2022. Participants included twelve patients, ten community pharmacists, and one general practitioner. Interviews were transcribed verbatim and analysed using thematic analysis. Only patient and pharmacist interviews were included.
Themes from the interviews included: 1) Access to care, 2) Technological changes, 3) Experiences of care, and 4) Patient safety. Particular challenges identified included the difficulty faced by patients when accessing care, impacts on experiences of patient care, and extensive changes to pharmacy practice during the pandemic.
This study found that COVID-19 countermeasures considerably impacted patient and pharmacist experiences of primary care in terms of care and medication safety. While many changes were welcomed, others such as virtual consultations were received more cautiously likely due to the rapid and unplanned nature of their introduction. Further research is needed to identify how to optimise these changes to improve pharmacist and patient experience, and to understand the impact on patient safety.
在新冠疫情期间,初级医疗保健领域引入了一系列旨在减少新冠病毒传播的重大变革。在爱尔兰,这些变革包括根本性的立法和实践改变,如允许电子处方传递、延长处方有效期以及鼓励虚拟会诊。尽管这些干预措施在预防感染传播方面发挥了重要作用,但其对实践和患者护理的影响尚不清楚。本研究的目的是调查患者以及医疗保健专业人员(药剂师和全科医生)的经历,以了解在爱尔兰新冠疫情的头两年中,新冠病毒对初级医疗保健和用药安全的影响。
2021年10月至2022年1月期间进行了一项采用半结构化访谈的定性研究。参与者包括12名患者、10名社区药剂师和1名全科医生。访谈内容逐字记录,并采用主题分析法进行分析。仅纳入患者和药剂师的访谈。
访谈得出的主题包括:1)获得医疗服务,2)技术变革,3)护理体验,4)患者安全。确定的具体挑战包括患者在获得医疗服务时面临的困难、对患者护理体验的影响以及疫情期间药房实践的广泛变化。
本研究发现,新冠疫情应对措施在护理和用药安全方面对患者和药剂师的初级医疗保健体验产生了重大影响。虽然许多变革受到欢迎,但其他一些变革,如虚拟会诊,由于其引入的迅速性和计划性不足,受到的接受程度更为谨慎。需要进一步研究以确定如何优化这些变革,以改善药剂师和患者的体验,并了解其对患者安全的影响。